Spire Healthcare Group (LON:SPI) Receives Buy Rating from Deutsche Bank Aktiengesellschaft

Spire Healthcare Group (LON:SPI)‘s stock had its “buy” rating reiterated by investment analysts at Deutsche Bank Aktiengesellschaft in a report issued on Friday,London Stock Exchange reports. They presently have a GBX 245 price target on the stock. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 8.11% from the stock’s current price.

Spire Healthcare Group Stock Performance

Shares of LON:SPI traded up GBX 2.13 during midday trading on Friday, reaching GBX 226.63. 57,164,754 shares of the company traded hands, compared to its average volume of 4,277,108. The firm’s fifty day moving average price is GBX 163.68 and its two-hundred day moving average price is GBX 185.52. The firm has a market capitalization of £907.86 million, a price-to-earnings ratio of 56.66, a price-to-earnings-growth ratio of 1.06 and a beta of 0.91. The company has a quick ratio of 0.74, a current ratio of 0.63 and a debt-to-equity ratio of 177.14. Spire Healthcare Group has a 12 month low of GBX 140.80 and a 12 month high of GBX 256.50.

Spire Healthcare Group (LON:SPI) last issued its earnings results on Friday, March 6th. The company reported GBX 9.60 EPS for the quarter. Spire Healthcare Group had a return on equity of 2.22% and a net margin of 1.04%. On average, equities analysts expect that Spire Healthcare Group will post 15.6634747 earnings per share for the current year.

Trending Headlines about Spire Healthcare Group

Here are the key news stories impacting Spire Healthcare Group this week:

• Positive Sentiment: Toscafund has reportedly made a £1 billion takeover proposal for Spire Healthcare, sending the shares sharply higher as investors price in a potential buyout premium. Spire Healthcare shares surge 38% on £1bn takeover proposal from Toscafund
• Positive Sentiment: Spire said it would support a £1 billion bid from Toscafund, reinforcing market expectations that a deal could move forward. Spire Healthcare says would back GBP1 billion bid from Toscafund
• Positive Sentiment: Reuters reported that Toscafund is proposing a $1.35 billion buyout of London-listed Spire Healthcare, adding further credibility to the takeover story. London’s Spire Healthcare gets $1.35 billion buyout proposal from Toscafund
• Positive Sentiment: Spire also confirmed full-year outlook and said private revenue is growing strongly, while maintaining 2026 earnings guidance after stable early-year trading. Spire Healthcare confirms full-year outlook as private revenue grows strongly
• Neutral Sentiment: Shareholders approved all resolutions at Spire’s 2026 AGM, which signals governance support but is less likely to be the main stock-moving driver. Spire Healthcare Wins Strong Shareholder Backing at 2026 AGM

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.